These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 18402387)
1. DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival. Zhao H; Yu H; Liu Y; Wang Y; Cai W Clin Neuropathol; 2008; 27(2):83-90. PubMed ID: 18402387 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas. Taniguchi K; Wakabayashi T; Yoshida T; Mizuno M; Yoshikawa K; Kikuchi A; Nakashima N; Yoshida J J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of topoisomerase II alpha and evaluation of its effects on cell proliferation and apoptosis in glioblastoma cancer stem cells. Hong Y; Sang M; Shang C; Xue YX; Liu YH Neurosci Lett; 2012 Jun; 518(2):138-43. PubMed ID: 22569122 [TBL] [Abstract][Full Text] [Related]
4. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Brustmann H; Naudé S Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target. Washiro M; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Sugimoto T; Seki N; Miyazaki M J Cancer Res Clin Oncol; 2008 Jul; 134(7):793-801. PubMed ID: 18204862 [TBL] [Abstract][Full Text] [Related]
6. The predictive and prognostic significance of pre- and post-treatment topoisomerase IIα in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer. Chen S; Huang L; Liu Y; Chen CM; Wu J; Shao ZM Eur J Surg Oncol; 2013 Jun; 39(6):619-26. PubMed ID: 23473851 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer. Järvinen TA; Holli K; Kuukasjärvi T; Isola JJ Br J Cancer; 1998 Jun; 77(12):2267-73. PubMed ID: 9649144 [TBL] [Abstract][Full Text] [Related]
8. Mitosin and DNA topoisomerase IIalpha: two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival. Korkolopoulou P; Patsouris E; Konstantinidou AE; Christodoulou P; Thomas-Tsagli E; Kouzelis K; Angelidakis D; Rologis D; Davaris P Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):207-14. PubMed ID: 11556747 [TBL] [Abstract][Full Text] [Related]
9. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer. Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293 [TBL] [Abstract][Full Text] [Related]
11. DNA topoisomerase IIalpha expression in optic pathway gliomas of childhood. Bredel M; Slavc I; Birner P; Czech T; Haberler C; Ströbel T; Wolfsberger S; Budka H; Hainfellner JA Eur J Cancer; 2002 Feb; 38(3):393-400. PubMed ID: 11818205 [TBL] [Abstract][Full Text] [Related]
12. β-Elemene Inhibits Cell Proliferation by Regulating the Expression and Activity of Topoisomerases I and IIα in Human Hepatocarcinoma HepG-2 Cells. Gong M; Liu Y; Zhang J; Gao YJ; Zhai PP; Su X; Li X; Li Y; Hou L; Cui XN Biomed Res Int; 2015; 2015():153987. PubMed ID: 26221582 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of topoisomerase IIalpha to rapidly evaluate cell proliferation in brain tumors. Oda M; Arakawa Y; Kano H; Kawabata Y; Katsuki T; Shirahata M; Ono M; Yamana N; Hashimoto N; Takahashi JA Biochem Biophys Res Commun; 2005 Jun; 331(4):971-6. PubMed ID: 15882973 [TBL] [Abstract][Full Text] [Related]
14. [The expression of MRP, GST-pi, Topo IIalpha and COX-2 in epithelial ovarian cancer and its relationship to drug resistance and prognosis]. Cao DY; Shen K; Yang JX; Guan J Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1738-41. PubMed ID: 17919376 [TBL] [Abstract][Full Text] [Related]
15. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior. Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas. Varughese RK; Skjulsvik AJ; Torp SH Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203 [TBL] [Abstract][Full Text] [Related]
17. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085 [TBL] [Abstract][Full Text] [Related]
18. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status. Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587 [TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival. Holden JA; Townsend JJ Mod Pathol; 1999 Dec; 12(12):1094-100. PubMed ID: 10619260 [TBL] [Abstract][Full Text] [Related]
20. Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome. Schrader C; Meusers P; Brittinger G; Teymoortash A; Siebmann JU; Janssen D; Parwaresch R; Tiemann M Leukemia; 2004 Jul; 18(7):1200-6. PubMed ID: 15116121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]